TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
2.330
+0.090 (4.02%)
At close: May 1, 2026, 4:00 PM EDT
2.300
-0.030 (-1.29%)
After-hours: May 1, 2026, 7:59 PM EDT
TuHURA Biosciences Market Cap
TuHURA Biosciences has a market cap or net worth of $148.14 million as of May 1, 2026. Its market cap has decreased by -18.08% in one year.
Market Cap
148.14M
Enterprise Value
145.22M
1-Year Change
-18.08%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since October 18, 2024, TuHURA Biosciences's market cap has decreased from $264.60M to $148.14M, a decrease of -44.01%. That is a compound annual growth rate of -31.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 148.14M | 222.41% |
| Dec 31, 2025 | 45.95M | -73.43% |
| Dec 31, 2024 | 172.94M | -34.64% |
| Oct 18, 2024 | 264.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alps Group | 149.76M |
| Galectin Therapeutics | 149.76M |
| Spero Therapeutics | 148.20M |
| Fate Therapeutics | 146.49M |
| InflaRx | 144.59M |
| Connect Biopharma Holdings | 139.61M |
| Edesa Biotech | 133.37M |
| Equillium | 132.14M |